Clinical Trials · NCT00186121
Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Stanford University
- Enrollment
- 35
- Start date
- Oct 2000
- Locations
- 1 site, United States
- Primary endpoint
- Objective Response Rate (ORR)